Next Article in Journal
Parathyroid Hormone-Related Protein (PTHrP): A Key Regulator of Life/Death Decisions by Tumor Cells with Potential Clinical Applications
Next Article in Special Issue
Metabolic Disorder, Inflammation, and Deregulated Molecular Pathways Converging in Pancreatic Cancer Development: Implications for New Therapeutic Strategies
Previous Article in Journal
Why Victory in the War on Cancer Remains Elusive: Biomedical Hypotheses and Mathematical Models
Previous Article in Special Issue
The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond Thrombosis
Article Menu

Export Article

Open AccessReview
Cancers 2011, 3(1), 368-395; doi:10.3390/cancers3010368

Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems

Programa Gens i Malaltia, Centre de Regulació Genòmica-CRG, UPF, Parc de Recerca Biomèdica de Barcelona-PRBB and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain
*
Author to whom correspondence should be addressed.
Received: 1 December 2010 / Revised: 5 January 2011 / Accepted: 13 January 2011 / Published: 18 January 2011
(This article belongs to the Special Issue Pancreatic Cancer)
View Full-Text   |   Download PDF [744 KB, uploaded 18 January 2011]   |  

Abstract

The continuous identification of molecular changes deregulating critical pathways in pancreatic tumor cells provides us with a large number of novel candidates to engineer gene-targeted approaches for pancreatic cancer treatment. Targets—both protein coding and non-coding—are being exploited in gene therapy to influence the deregulated pathways to facilitate cytotoxicity, enhance the immune response or sensitize to current treatments. Delivery vehicles based on viral or non-viral systems as well as cellular vectors with tumor homing characteristics are a critical part of the design of gene therapy strategies. The different behavior of tumoral versus non-tumoral cells inspires vector engineering with the generation of tumor selective products that can prevent potential toxic-associated effects. In the current review, a detailed analysis of the different targets, the delivery vectors, the preclinical approaches and a descriptive update on the conducted clinical trials are presented. Moreover, future possibilities in pancreatic cancer treatment by gene therapy strategies are discussed. View Full-Text
Keywords: viral and non-viral vectors; oncolysis; gene delivery routes; clinical trials viral and non-viral vectors; oncolysis; gene delivery routes; clinical trials
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Fillat, C.; Jose, A.; Bofill-De Ros, X.; Mato-Berciano, A.; Maliandi, M.V.; Sobrevals, L. Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems. Cancers 2011, 3, 368-395.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top